Single Cell is heading south in February to take part in hubXchange’s San Diego Antibody Therapeutics Xchange 2024. We’re looking forward to meeting with pharma and biotech companies to discuss how we can help them advance antibody discovery with our AbTheneum™ antibody platform.
